News & Events

• August 25, 2023
  

  C-Path’s Role in IHI Call 4: Enhancing Rare Disease Clinical Trials

  This memo outlines how C-Path can contribute as a key strategic regulatory partner to the Innovative Health Initiative’s (IHI) call 4, “Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases.” We encourage potential partners to review the memo and reach out as early as possible to rdcadap@c-path.org with interest.   On 27 July 2023, the......
• January 23, 2023
  

  C-Path and Mobilise-D Collaborate to Improve Impact on the Organizations’ Common Goals

      Critical Path Institute is pleased to announce the recent collaboration agreement between C-Path and Mobilise-D. By combining C-Path’s unique global regulatory expertise and Mobilise-D’s focus on digital assessment of mobility, this mutually beneficial partnership aims to accelerate and improve the impact of these important initiatives that share common goals. The Critical Path for......